Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Jan Geissler: Shaping the Future of Hematology Research at EHA CRTH
Jan Geissler/LinkedIn
Sep 6, 2026, 12:06

Jan Geissler: Shaping the Future of Hematology Research at EHA CRTH

Jan Geissler, Founder and CEO of Patvocates, shared a post on LinkedIn:

“Just back from five days deep in the French woods, investing in the people who will shape tomorrow’s haematology research.

For the fourth year, I had the privilege of serving on the faculty of the European Hematology Association (EHA) Clinical Research Training in Hematology (CRTH) programme at Bellinglise Castle, France .

And I love CRTH.

There is something super rewarding about working with young, supersmart clinical researchers who are full of ideas, curiosity and enthusiasm – and, importantly, not yet fixed in how clinical research ‘should be’ and ‘has always been’ done.

These are the clinicians and investigators who will design tomorrow’s trials.

So we spent quite some time making the patient perspective difficult to ignore:

  • Would you honestly offer your own trial to your patients?
  • Who are your eligibility criteria quietly excluding?
  • Are you measuring what actually matters to patients?
  • Does informed consent result in understanding, or merely a signature?
  • Who owns and controls samples in a biobank?

And what use is patient literacy if it doesn’t ultimately give patients agency?

My sessions covered patient involvement in trial design and participation, patient-reported outcomes and treatment tolerability, ethical questions around biobanking, and patient literacy about research.

What I particularly like: these topics aren’t sitting in some separate ‘and now let’s hear from a patient’ corner.

They are embedded alongside statistics, data management, precision medicine, DEI, real-world evidence, AI and translational research.

Patient engagement shouldn’t be something researchers discover after their first protocol has failed to recruit.

It should be part of how we teach people to become clinical researchers in the first place.

A huge thank you to course directors Sirpa Leppa and Verena Gaidzik, and to European Hematology Association (EHA) and all the faculty for putting patient involvement so firmly at the heart of CRTH.

And deep thanks to Jennifer Scheffer and Audrey Urighe for managing this demanding but very sweet crowd with so much humour, patience and professionalism.

The CRTH class of 2026 has graduated.

I feel proud, grateful and optimistic about what these people will do next.

Our paths will cross again, I am sure.

Hematology is such a great space for innovation and patient advocacy.

For those early-career hematologists who want to go through this amazing programme in 2027: Applications are open until 15 Sept 2026!

Apply Now!”

Jan Geissler: Shaping the Future of Hematology Research at EHA CRTH

Stay updated with Hemostasis Today.

AI in Healthcare Biobanking Clinical Research Clinical Trial Design clinical trials Data Management evidence-based medicine Healthcare Innovation Hematology Hematology Education Hematology Research Hemostasis News Hemostasis Today Jan Geissler Medical Research Oncology Research Patient Centred Research Patient Engagement Patient Involvement Patient Literacy Patient Reported Outcomes Precision Medicine Real World Evidence translational research Treatment Tolerability
NewsFeed